No Longer Just CBD - Ananda Professional Re-Writes the Category With Its New Condition-Driven Minor Cannabinoid Range
February 06, 2023 10:00 ET
|
Ananda Professional
GEORGETOWN, Ky., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Ananda Professional's multimillion-dollar research program continues to lead the way in identifying novel ways to leverage cannabinoids for the...
Canadian Treatments for COVID-19 (CATCO) Trial Receives Approval from Health Canada to Amend Protocol to include LSALT Peptide (Metablok)
February 14, 2022 07:30 ET
|
Arch Biopartners
TORONTO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch Biopartners”, “Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug...
Open Book Extracts Raises $11.5M Series B Funding Round to Accelerate Global Growth
June 02, 2021 07:00 ET
|
Open Book Extracts
ROXBORO, N.C., June 02, 2021 (GLOBE NEWSWIRE) -- Open Book Extracts (OBX), a Roxboro, NC-based leading ingredient manufacturer and product development house for the industry’s most innovative and...
Sikh Group Sues the MacDonald-Laurier Institute and former CBC Journalist Terry Milewski over Khalistan Report
December 23, 2020 06:00 ET
|
Sikhs For Justice
TORONTO, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Claiming malicious, misleading and baseless accusations, Sikhs For Justice (SFJ) filed a defamation lawsuit with the Ontario Superior Court of...
Arch Biopartners Receives Approval from Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide; Begins Screening Patients in Florida
October 07, 2020 07:58 ET
|
Arch Biopartners
TORONTO, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received approval in Turkey from the Ministry...
Broward Health Medical Center Becomes First Clinical Site in U.S. for Phase II Trial for LSALT Peptide
July 28, 2020 08:13 ET
|
Arch Biopartners
TORONTO, July 28, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating...
Open Book Extracts Acquires Chilmark Labs to Commercialize Rare Cannabinoids and Pioneer Scientific Research and Technologies for the CBD Industry
June 15, 2020 07:00 ET
|
Open Book Extracts
ROXBORO, N.C., June 15, 2020 (GLOBE NEWSWIRE) -- Open Book Extracts, one of the leading vertically integrated, cGMP certified processors of high-quality cannabinoid products, is pleased to announce...
Engångsintäkt på 5 miljoner kronor till Iconovo
March 19, 2019 16:17 ET
|
Iconovo AB publ
I ett pågående kundprojekt med CBC Co Ltd har Iconovo och kunden kommit överens om att förändra betalningsmodellen vilket gör att Iconovo nu kan intäktsföra en engångsintäkt på cirka 5 miljoner...
Avid and CBC/Radio-Canada Renew Multiyear Enterprise Support Agreement
July 24, 2018 08:00 ET
|
Avid Technology, Inc.
BURLINGTON, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- Avid® (Nasdaq:AVID), the leading technology provider of software tools and platforms that power the media and entertainment industry, today...
RTDNA Canada congratulates Bernard St-Laurent, James Stewart and Brian Thomas as recipients of the Lifetime Achievement Award in the Central Region
May 02, 2018 15:25 ET
|
RTDNA Canada
TORONTO, Ontario, May 02, 2018 (GLOBE NEWSWIRE) -- RTDNA Canada is pleased to recognize three outstanding individuals in the Central region who have distinguished themselves through outstanding...